Free Trial
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel
NASDAQ:SDGR

Schrodinger Q3 2026 Earnings Date & Estimates

Schrodinger logo
$27.53 +1.14 (+4.32%)
As of 02:29 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Schrodinger is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes. The conference call is scheduled for 4:30 PM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
After Market Closes
Conference Call
4:30 PM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Schrodinger in Q3 2026

Schrodinger is expected to post earnings of -$0.66 per share on revenue of $48.55 million. In the same quarter a year earlier Schrodinger reported -$0.45 per share on revenue of $54.32 million. Schrodinger last reported on August 5, 2026, posting $0.08 per share and beating the -$0.4145 consensus estimate. Schrodinger has beaten the consensus EPS estimate in 4 of its last 8 quarters.

Consensus Estimates

Consensus EPS
-$0.66
Expected Revenue
$48.55 million
Prior-Year EPS
-$0.45
Prior-Year Revenue
$54.32 million
Expected Revenue Growth
-10.6%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
$0.08 (Beat by +$0.4945)
Last Quarter Revenue
$58.89 million
EPS Beat Rate
4 of last 8 quarters

Prepare for the Q3 2026 Call

Schrodinger Q3 2026 Earnings FAQ

Schrodinger (NASDAQ:SDGR) is scheduled to report Q3 2026 earnings on Wednesday, November 4, 2026, after market closes.

Schrodinger's Q3 2026 earnings conference call is scheduled for Wednesday, November 4, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Schrodinger to post earnings of -$0.66 per share for Q3 2026.

The consensus revenue estimate for Schrodinger is $48.55 million for Q3 2026.

Schrodinger Earnings Headlines

Schrodinger (NASDAQ:SDGR) Raised to Strong-Buy at Zacks Research
October 7 at 7:33 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31095999
Schrodinger (NASDAQ:SDGR) Reaches New 52-Week High - What's Next?
October 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31078665
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
October 9 at 1:00 AM  |  Banyan Hill Publishing (Ad)
Schrödinger (SDGR) Could Be 29% Below Fair Value Despite A 38% Overvalued View
September 27, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/schr-dinger-sdgr-could-29-200558709.html
Schrodinger Stock Has Technical Strength as It Hits New 2-Year Highs
September 23, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/schrodinger-stock-technical-strength-hits-175003541.html
Why DataMEDS’ acquisition does not seem to be very bullish for MEDS stock at this point
September 18, 2026  |  msn.comhttps://www.msn.com/en-us/money/general/why-datameds-acquisition-does-not-seem-to-be-very-bullish-for-meds-stock-at-this-point/ar-AA2cxeSl
See More Schrodinger Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Schrodinger? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Schrodinger and other key companies, straight to your email.

About Schrodinger

Schrödinger, Inc. is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties.

The company’s software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign. Schrödinger licenses its software to pharmaceutical, biotechnology, chemical and academic organizations worldwide, while also applying the platform to its own internal drug discovery programs and strategic collaborations.

Founded in 1990, Schrödinger is named after physicist Erwin Schrödinger and is headquartered in New York City. The company is led by President and Chief Executive Officer Ramy Farid, who has overseen its development as both a scientific software provider and a biopharmaceutical research company.

View Schrodinger Profile
Earnings Tools